Compounds > 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
Page last updated: 2024-10-21

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Autosomal Dominant Juvenile Parkinson Disease

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one : A member of the class of oxadiazoloquinoxalines that is 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline substituted at position 1 by an oxo group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tseng, KY1
Caballero, A1
Dec, A1
Cass, DK1
Simak, N1
Sunu, E1
Park, MJ1
Blume, SR1
Sammut, S1
Park, DJ1
West, AR1

Other Studies

1 other study available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Inhibition of striatal soluble guanylyl cyclase-cGMP signaling reverses basal ganglia dysfunction and akinesia in experimental parkinsonism.
    PloS one, 2011, Volume: 6, Issue:11

    Topics: Animals; Basal Ganglia; Corpus Striatum; Cyclic GMP; Enzyme Inhibitors; Guanylate Cyclase; Male; Mic

2011